當前位置：首頁 SCI期刊 SCIE期刊醫學中科院4區 JCRQ3 期刊介紹(非官網)

Advances In Clinical And Experimental MedicineSCIE

國際簡稱：ADV CLIN EXP MED 參考譯名：臨床和實驗醫學進展

中科院分區
4區
CiteScore分區
Q1
JCR分區
Q3

基本信息：: ISSN：1899-5276; E-ISSN：2451-2680; 是否OA：開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：POLAND; 出版商：Wroclaw Medical University; 出版語言：English; 出版周期：Monthly; 出版年份：1998; 研究方向：MEDICINE, RESEARCH & EXPERIMENTAL

評價信息：: 影響因子：2.1; H-index：21; CiteScore指數：3.7; SJR指數：0.535; SNIP指數：0.61

發文數據：: Gold OA文章占比：94.51%; 研究類文章占比：85.56%; 年發文量：187; 自引率：0.0476...; 開源占比：0.9864; 出版撤稿占比：0; 出版國人文章占比：0.14; OA被引用占比：0.8215...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Advances In Clinical And Experimental Medicine期刊介紹

Advances in Clinical and Experimental Medicine has been published by the Wroclaw Medical University since 1992. Establishing the medical journal was the idea of Prof. Bogumi? Halawa, Chair of the Department of Cardiology, and was fully supported by the Rector of Wroclaw Medical University, Prof. Zbigniew Knapik. Prof. Halawa was also the first editor-in-chief, between 1992-1997. The journal, then entitled "Post?py Medycyny Klinicznej i Do?wiadczalnej", appeared quarterly.

Prof. Leszek Paradowski was editor-in-chief from 1997-1999. In 1998 he initiated alterations in the profile and cover design of the journal which were accepted by the Editorial Board. The title was changed to Advances in Clinical and Experimental Medicine. Articles in English were welcomed. A number of outstanding representatives of medical science from Poland and abroad were invited to participate in the newly established International Editorial Staff.

Prof. Antonina Har?ozińska-Szmyrka was editor-in-chief in years 2000-2005, in years 2006-2007 once again prof. Leszek Paradowski and prof. Maria Podolak-Dawidziak was editor-in-chief in years 2008-2016. Since 2017 the editor-in chief is prof. Maciej Bag?aj.

Since July 2005, original papers have been published only in English. Case reports are no longer accepted. The manuscripts are reviewed by two independent reviewers and a statistical reviewer, and English texts are proofread by a native speaker.

The journal has been indexed in several databases: Scopus, Ulrich’sTM International Periodicals Directory, Index Copernicus and since 2007 in Thomson Reuters databases: Science Citation Index Expanded i Journal Citation Reports/Science Edition.

In 2010 the journal obtained Impact Factor which is now 1.179 pts. Articles published in the journal are worth 15 points among Polish journals according to the Polish Committee for Scientific Research and 169.43 points according to the Index Copernicus.

Since November 7, 2012, Advances in Clinical and Experimental Medicine has been indexed and included in National Library of Medicine’s MEDLINE database. English abstracts printed in the journal are included and searchable using PubMed http://www.ncbi.nlm.nih.gov/pubmed.

期刊簡介Advances In Clinical And Experimental Medicine期刊介紹

《Advances In Clinical And Experimental Medicine》自1998出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：較慢,6-12周
醫學
MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
中科院4區
非預警

Cite Score數據（2024年最新版）Advances In Clinical And Experimental Medicine Cite Score數據

CiteScore：3.7
SJR：0.535
SNIP：0.61

學科類別	分區	排名	百分位
大類：Medicine 小類：Reviews and References (medical)	Q1	1 / 5	90%
大類：Medicine 小類：Medicine (miscellaneous)	Q2	149 / 398	62%
大類：Medicine 小類：General Biochemistry, Genetics and Molecular Biology	Q2	104 / 221	53%
大類：Medicine 小類：Internal Medicine	Q2	80 / 167	52%
大類：Medicine 小類：Pharmacology (medical)	Q2	135 / 272	50%
大類：Medicine 小類：Genetics (clinical)	Q3	61 / 99	38%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Advances In Clinical And Experimental Medicine 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	4區	MEDICINE, RESEARCH & EXPERIMENTAL 醫學：研究與實驗	4區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Advances In Clinical And Experimental Medicine JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q3	118 / 189	37.8%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q4	142 / 189	25.13%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
Poland425
CHINA MAINLAND100
Turkey53
USA18
Iran13
GERMANY (FED REP GER)12
Czech Republic10
Italy7
South Korea5
England4

本刊中國學者近年發表論文

1、Meta-analysis of outcomes related to the quality of life after orthodontic-surgical treatment
Author: Li, Xiangyu; Zheng, Weiying; Zhang, Xi; Zhang, Yumen

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.17219/acem/161490
2、Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways
Author: Wang, Manfeng; Liu, Meiling; Xu, Wanzhen; Teng, Zongyan; Wu, Xiaowei; Gan, Lu; Zhang, Yina

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 32, Issue 4, pp. -. DOI: 10.17219/acem/155342
3、A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-beta 1/Smads pathway
Author: Zhang, Ronghua; Wang, Meimei; Lu, Hongjian; Wang, Jingyao; Han, Xiangyang; Liu, Zhiyong; Li, Lin; Li, Mingming; Tian, Xiaoli; Chen, Shuang; Zhang, Guangling; Xiong, Yanan; Li, Jingwu

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 32, Issue 4, pp. -. DOI: 10.17219/acem/154996
4、The relationship between non-alcoholic fatty liver disease and incidence of chronic kidney disease for diabetic and non-diabetic subjects: A meta-analysis
Author: Chen, Yueqiao; Bai, Wenjie; Mao, Dewen; Long, Fuli; Wang, Na; Wang, Kejing; Shi, Qinglan

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 32, Issue 4, pp. -. DOI: 10.17219/acem/155017
5、The relationship between LRP5 rs556442 and rs638051 polymorphisms and mutations and their influence on bone metabolism in postmenopausal Xinjiang women with type 2 diabetes
Author: Song, Minli; Li, Jun; Li, Siyuan; Wang, Xiling; Zhao, Huirong; Hou, Zexing

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 32, Issue 4, pp. -. DOI: 10.17219/acem/155110
6、Serum TBK1 levels are correlated with inflammation, optic nerve sheath diameter and intracranial pressure in severe traumatic brain injury patients under deep sedation
Author: Zhuang, Shuilong; Xu, Qing; Li, Youfu; Hu, Ke; Xia, Zhengcai; Zhang, Lin

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 32, Issue 4, pp. -. DOI: 10.17219/acem/155040
7、Awareness and practice of preventive measures among healthcare workers in medical institutions in Beijing during influenza season on the eve of COVID-19 epidemic: A cross-sectional survey
Author: Xie, Mei-Lian; Zhang, Jun-Xia; Zhang, Zhi-Yun; Lin, Zhao-Xia

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 32, Issue 4, pp. -. DOI: 10.17219/acem/154998
8、Does autologous fat grafting serve the need for reconstructive surgery in oral cancer patients? A prospective evaluation in cosmetic surgery patients
Author: Gao, Feng; Huo, Ran; Wang, Fagang; Lv, Renrong; Xue, Feng; Zhang, Jian; Xu, Guangqi; Bi, Jianhai; Meng, Zhen; Fu, Cong

Journal: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.17219/acem/161163